Pulmonary lymphoma in Sjogren's syndrome

L. A. Hansen, U. B S Prakash, T. V. Colby

Research output: Contribution to journalArticle

Abstract

Sjogren's syndrome (SS) is an immunologic disease characterized by progressive destruction of the exocrine glands that causes mucosal and conjunctival dryness. In addition to the common pulmonary complications of diffuse interstitial lung disease, airways obstruction, desiccation of the upper respiratory tract, localized parenchymal nodules, recurrent tracheobronchitis, bronchiectasis, interstitial pneumonitis, and pleural effusion, patients with SS have a high risk of developing non-Hodgkin's lymphoma that may affect the lungs. Among 50 patients with SS and associated lymphoma, 10 had pulmonary involvement by lymphoma. The mean age of these 10 patients was 59.7 years, and 8 were women. The mean duration of SS was 7.2 years, and the mean interval between the onset of SS and lymphoma was 5.4 years. Cough and slow progressive dyspnea were the most common pulmonary symptoms, and chest roentgenographic findings varied. Lung biopsies revealed a spectrum of low- to high-grade lymphomas, and high-grade lymphomas were associated with increased mortality. Of the 10 patients, 4 died from 8 to 48 months after lymphoma was diagnosed. We conclude that pulmonary involvement is common in patients with lymphoma associated with SS; thus, lymphoma should be considered in the differential diagnosis of pulmonary lesions in patients with SS.

Original languageEnglish (US)
Pages (from-to)921-931
Number of pages11
JournalMayo Clinic Proceedings
Volume64
Issue number8
StatePublished - 1989

Fingerprint

Sjogren's Syndrome
Lymphoma
Lung
Non-Hodgkin's Lymphoma
Interstitial Lung Diseases
Exocrine Glands
Desiccation
Bronchiectasis
Immune System Diseases
Airway Obstruction
Pleural Effusion
Cough
Respiratory System
Dyspnea
Differential Diagnosis
Thorax
Biopsy
Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Hansen, L. A., Prakash, U. B. S., & Colby, T. V. (1989). Pulmonary lymphoma in Sjogren's syndrome. Mayo Clinic Proceedings, 64(8), 921-931.

Pulmonary lymphoma in Sjogren's syndrome. / Hansen, L. A.; Prakash, U. B S; Colby, T. V.

In: Mayo Clinic Proceedings, Vol. 64, No. 8, 1989, p. 921-931.

Research output: Contribution to journalArticle

Hansen, LA, Prakash, UBS & Colby, TV 1989, 'Pulmonary lymphoma in Sjogren's syndrome', Mayo Clinic Proceedings, vol. 64, no. 8, pp. 921-931.
Hansen LA, Prakash UBS, Colby TV. Pulmonary lymphoma in Sjogren's syndrome. Mayo Clinic Proceedings. 1989;64(8):921-931.
Hansen, L. A. ; Prakash, U. B S ; Colby, T. V. / Pulmonary lymphoma in Sjogren's syndrome. In: Mayo Clinic Proceedings. 1989 ; Vol. 64, No. 8. pp. 921-931.
@article{ccb021a3af1a48b89f9eb6d811ad97e4,
title = "Pulmonary lymphoma in Sjogren's syndrome",
abstract = "Sjogren's syndrome (SS) is an immunologic disease characterized by progressive destruction of the exocrine glands that causes mucosal and conjunctival dryness. In addition to the common pulmonary complications of diffuse interstitial lung disease, airways obstruction, desiccation of the upper respiratory tract, localized parenchymal nodules, recurrent tracheobronchitis, bronchiectasis, interstitial pneumonitis, and pleural effusion, patients with SS have a high risk of developing non-Hodgkin's lymphoma that may affect the lungs. Among 50 patients with SS and associated lymphoma, 10 had pulmonary involvement by lymphoma. The mean age of these 10 patients was 59.7 years, and 8 were women. The mean duration of SS was 7.2 years, and the mean interval between the onset of SS and lymphoma was 5.4 years. Cough and slow progressive dyspnea were the most common pulmonary symptoms, and chest roentgenographic findings varied. Lung biopsies revealed a spectrum of low- to high-grade lymphomas, and high-grade lymphomas were associated with increased mortality. Of the 10 patients, 4 died from 8 to 48 months after lymphoma was diagnosed. We conclude that pulmonary involvement is common in patients with lymphoma associated with SS; thus, lymphoma should be considered in the differential diagnosis of pulmonary lesions in patients with SS.",
author = "Hansen, {L. A.} and Prakash, {U. B S} and Colby, {T. V.}",
year = "1989",
language = "English (US)",
volume = "64",
pages = "921--931",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "8",

}

TY - JOUR

T1 - Pulmonary lymphoma in Sjogren's syndrome

AU - Hansen, L. A.

AU - Prakash, U. B S

AU - Colby, T. V.

PY - 1989

Y1 - 1989

N2 - Sjogren's syndrome (SS) is an immunologic disease characterized by progressive destruction of the exocrine glands that causes mucosal and conjunctival dryness. In addition to the common pulmonary complications of diffuse interstitial lung disease, airways obstruction, desiccation of the upper respiratory tract, localized parenchymal nodules, recurrent tracheobronchitis, bronchiectasis, interstitial pneumonitis, and pleural effusion, patients with SS have a high risk of developing non-Hodgkin's lymphoma that may affect the lungs. Among 50 patients with SS and associated lymphoma, 10 had pulmonary involvement by lymphoma. The mean age of these 10 patients was 59.7 years, and 8 were women. The mean duration of SS was 7.2 years, and the mean interval between the onset of SS and lymphoma was 5.4 years. Cough and slow progressive dyspnea were the most common pulmonary symptoms, and chest roentgenographic findings varied. Lung biopsies revealed a spectrum of low- to high-grade lymphomas, and high-grade lymphomas were associated with increased mortality. Of the 10 patients, 4 died from 8 to 48 months after lymphoma was diagnosed. We conclude that pulmonary involvement is common in patients with lymphoma associated with SS; thus, lymphoma should be considered in the differential diagnosis of pulmonary lesions in patients with SS.

AB - Sjogren's syndrome (SS) is an immunologic disease characterized by progressive destruction of the exocrine glands that causes mucosal and conjunctival dryness. In addition to the common pulmonary complications of diffuse interstitial lung disease, airways obstruction, desiccation of the upper respiratory tract, localized parenchymal nodules, recurrent tracheobronchitis, bronchiectasis, interstitial pneumonitis, and pleural effusion, patients with SS have a high risk of developing non-Hodgkin's lymphoma that may affect the lungs. Among 50 patients with SS and associated lymphoma, 10 had pulmonary involvement by lymphoma. The mean age of these 10 patients was 59.7 years, and 8 were women. The mean duration of SS was 7.2 years, and the mean interval between the onset of SS and lymphoma was 5.4 years. Cough and slow progressive dyspnea were the most common pulmonary symptoms, and chest roentgenographic findings varied. Lung biopsies revealed a spectrum of low- to high-grade lymphomas, and high-grade lymphomas were associated with increased mortality. Of the 10 patients, 4 died from 8 to 48 months after lymphoma was diagnosed. We conclude that pulmonary involvement is common in patients with lymphoma associated with SS; thus, lymphoma should be considered in the differential diagnosis of pulmonary lesions in patients with SS.

UR - http://www.scopus.com/inward/record.url?scp=0024433998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024433998&partnerID=8YFLogxK

M3 - Article

VL - 64

SP - 921

EP - 931

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 8

ER -